Mandatory Notifications of Trade by Primary Insiders

06 Mar 2026 15:54 CET

Helsinki, Finland, 6 March 2026: Charles MacBain and Didier Breton, primary
insiders of Nordhealth AS (the "Company"), have purchased class A shares in the
Company.

Please refer to the attached notifications of trading for further details.

For further information, please contact:

Charles MacBain, CEO charles.macbain@nordhealth.com

Alexander Cram, CFO alexander.cram@nordhealth.com

This information is subject to disclosure requirements set out in the EU Market
Abuse Regulation (EU) No 596/2014 Article 19 and the Norwegian Securities
Trading Act Section 5-12.

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 60,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with 400 employees working
either remotely or from offices (collaboration hubs). Visit the company's
website at nordhealth.com (http://www.nordhealth.com).

More information:
Access the news on Oslo Bors NewsWeb site

667745_Attachment_Notification_of_transaction_Breton_22240298_1.pdf
667745_Attachment_Notification_of_transaction_MacBain_22240307_1.pdf